Novel 'phage display antibodies identify distinct heparan sulfate domains in developing mammalian lung

Pediatric Surgery International

Volumn 23, Issue 5, 2007, Pages 411-417

  Thompson, S M ^a   Connell, M G ^a   Fernig, D G ^a   Ten Dam, G B ^b   Van Kuppevelt, T H ^b   Turnbull, J E ^a   Jesudason, E C ^a   Losty, P D ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME ANTIBODY; EPITOPE; GELATIN; HEPARAN SULFATE ANTIBODY EW4G2V; PARAFORMALDEHYDE; PHOSPHATE BUFFERED SALINE; PROTEOGLYCAN; PROTEOHEPARAN SULFATE; SUCROSE; UNCLASSIFIED DRUG;

AIRWAY; ANIMAL TISSUE; BASEMENT MEMBRANE; CAUSE OF DEATH; CELL COMPARTMENTALIZATION; CONFERENCE PAPER; CONGENITAL DIAPHRAGM HERNIA; CONTROLLED STUDY; CRYOPRESERVATION; EPITHELIUM CELL; GESTATIONAL AGE; IMMUNOHISTOCHEMISTRY; LUNG; LUNG DEVELOPMENT; LUNG HYPOPLASIA; MAMMAL; MESENCHYME; MESENCHYME CELL; MOLECULAR PROBE; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; SPRAGUE DAWLEY RAT; STAINING; TISSUE DISTRIBUTION; TISSUE SECTION;

ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; EPITOPES; HEPARAN SULFATE PROTEOGLYCANS; HEPARITIN SULFATE; IMMUNOHISTOCHEMISTRY; LUNG; PEPTIDE LIBRARY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 34247269714     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00383-006-1864-8     Document Type: Conference Paper

References (44)

1. Bellusci S, Grindley J, Emoto H, Itoh N, Hogan BL (1997) Fibroblast growth factor 10 (FGF10) and branching morphogenesis in the embryonic mouse lung. Development 124:4867-4878
2. Lebeche D, Malpel S, Cardoso WV (1999) Fibroblast growth factor interactions in the developing lung. Mech Dev 86:125-136
3. Nogawa H, Ito T (1995) Branching morphogenesis of embryonic mouse lung epithelium in mesenchyme-free culture. Development 121:1015-1022
4. Nielsen HC, Martin A, Volpe MV, Hatzis D, Vosatka RJ (1997) Growth factor control of growth and epithelial differentiation in embryonic lungs. Biochem Mol Med 60:38-48
5. Warburton D, Seth R, Shum L, Horcher PG, Hall FL, Werb Z, Slavkin HC (1992) Epigenetic role of epidermal growth factor expression and signalling in embryonic mouse lung morphogenesis. Dev Biol 149:123-133
6. Sonnenberg E, Meyer D, Weidner KM, Birchmeier C (1993) Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol 123:223-235
7. Kaartinen V, Voncken JW, Shuler C, Warburton D, Bu D, Heisterkamp N, Groffen J (1995) Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 11:415-421
8. Pelton RW, Hogan BL, Miller DA, Moses HL (1990) Differential expression of genes encoding TGFs beta 1, beta 2, and beta 3 during murine palate formation. Dev Biol 141:456-460
9. Batchelor DC, Hutchins AM, Klempt M, Skinner SJ (1995) Developmental changes in the expression patterns of IGFs, type 1 IGF receptor and IGF-binding proteins-2 and -4 in perinatal rat lung. J Mol Endocrinol 15:105-115
10. Lallemand AV, Ruocco SM, Joly PM, Gaillard DA (1995) In vivo localization of the insulin-like growth factors I and II (IGF I and IGF II) gene expression during human lung development. Int J Dev Biol 39:529-537
11. Maitre B, Clement A, Williams MC, Brody JS (1995) Expression of insulin-like growth factor receptors 1 and 2 in the developing lung and their relation to epithelial cell differentiation. Am J Respir Cell Mol Biol 13:262-270
12. Retsch-Bogart GZ, Moats-Staats BM, Howard K, D'Ercole AJ, Stiles AD (1996) Cellular localization of messenger RNAs for insulin-like growth factors (IGFs), their receptors and binding proteins during fetal rat lung development. Am J Respir Cell Mol Biol 14:61-69
13. Esko JD, Lindahl U (2001) Molecular diversity of heparan sulfate. J Clin Invest 108:169-173
14. Turnbull JE, Gallagher JT (1991) Distribution of iduronate 2-sulphate residues in heparan sulphate. Evidence for an ordered polymeric structure. Biochem J 273(Pt 3):553-559
15. van Kuppevelt TH, Dennissen MA, van Venrooij WJ, Hoet RM, Veerkamp JH (1998) Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney. J Biol Chem 273:12960-12966
16. Stickens D, Zak BM, Rougier N, Esko JD, Werb Z (2005) Mice deficient in Ext2 lack heparan sulfate and develop exostoses. Development 132:5055-5068
17. Lin X, Wei G, Shi Z, Dryer L, Esko JD, Wells DE, Matzuk MM (2000) Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice. Dev Biol 224:299-311
18. Bornemann DJ, Duncan JE, Staatz W, Selleck S, Warrior R (2004) Abrogation of heparan sulfate synthesis in Drosophila disrupts the Wingless, Hedgehog and Decapentaplegic signaling pathways. Development 131:1927-1938
19. Takei Y, Ozawa Y, Sato M, Watanabe A, Tabata T (2004) Three Drosophila EXT genes shape morphogen gradients through synthesis of heparan sulfate proteoglycans. Development 131:73-82
20. Grobe K, Inatani M, Pallerla SR, Castagnola J, Yamaguchi Y, Esko JD (2005) Cerebral hypoplasia and craniofacial defects in mice lacking heparan sulfate Ndst1 gene function. Development 132:3777-3786
21. Fan G, Xiao L, Cheng L, Wang X, Sun B, Hu G (2000) Targeted disruption of NDST-1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice. FEBS Lett 467:7-11
22. Ringvall M, Ledin J, Holmborn K, van Kuppevelt T, Ellin F, Eriksson I, Olofsson AM, Kjellen L, Forsberg E (2000) Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/N- sulfotransferase-1. J Biol Chem 275:25926-25930
23. Lin X, Buff EM, Perrimon N, Michelson AM (1999) Heparan sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development. Development 126:3715-3723
24. Li JP, Gong F, Hagner-McWhirter A, Forsberg E, Abrink M, Kisilevsky R, Zhang X, Lindahl U (2003) Targeted disruption of a murine glucuronyl C5-epimerase gene results in heparan sulfate lacking L-iduronic acid and in neonatal lethality. J Biol Chem 278:28363-28366
25. Peters K, Werner S, Liao X, Wert S, Whitsett J, Williams L (1994) Targeted expression of a dominant negative FGF receptor blocks branching morphogenesis and epithelial differentiation of the mouse lung. Embo J 13:3296-3301
26. Celli G, LaRochelle WJ, Mackem S, Sharp R, Merlino G (1998) Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning. Embo J 17:1642-1655
27. De Moerlooze L, Spencer-Dene B, Revest J, Hajihosseini M, Rosewell I, Dickson C (2000) An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development 127:483-492
28. Rapraeger AC, Krufka A, Olwin BB (1991) Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252:1705-1708
29. Ornitz DM, Yayon A, Flanagan JG, Svahn CM, Levi E, Leder P (1992) Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol Cell Biol 12:240-247
30. Delehedde M, Seve M, Sergeant N, Wartelle I, Lyon M, Rudland PS, Fernig DG (2000) Fibroblast growth factor-2 stimulation of p42/44MAPK phosphorylation and IkappaB degradation is regulated by heparan sulfate/heparin in rat mammary fibroblasts. J Biol Chem 275:33905-33910
31. Sutherland D, Samakovlis C, Krasnow MA (1996) branchless encodes a Drosophila FGF homolog that controls tracheal cell migration and the pattern of branching. Cell 87:1091-1101
32. Min H, Danilenko DM, Scully SA, Bolon B, Ring BD, Tarpley JE, DeRose M, Simonet WS (1998) Fgf-10 is required for both limb and lung development and exhibits striking functional similarity to Drosophila branchless. Genes Dev 12:3156-3161
33. Izvolsky KI, Zhong L, Wei L, Yu Q, Nugent MA, Cardoso WV (2003) Heparan sulfates expressed in the distal lung are required for Fgf10 binding to the epithelium and for airway branching. Am J Physiol Lung Cell Mol Physiol 285:L838-846
34. Izvolsky KI, Shoykhet D, Yang Y, Yu Q, Nugent MA, Cardoso WV (2003) Heparan sulfate-FGF10 interactions during lung morphogenesis. Dev Biol 258:185-200
35. Jesudason EC, Connell MG, Fernig DG, Lloyd DA, Losty PD (2000) Heparin and in-vitro experimental lung hypoplasia. Pediatr Surg Int 16:247-251
36. Knox S, Merry C, Stringer S, Melrose J, Whitelock J (2002) Not all perlecans are created equal: interactions with fibroblast growth factor (FGF) 2 and FGF receptors. J Biol Chem 277:14657-14665
37. Kato M, Wang H, Bernfield M, Gallagher JT, Turnbull JE (1994) Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains. J Biol Chem 269:18881-18890
38. Guimond SE, Turnbull JE (1999) Fibroblast growth factor receptor signalling is dictated by specific heparan sulphate saccharides. Curr Biol 9:1343-1346
39. Aviezer D, Levy E, Safran M, Svahn C, Buddecke E, Schmidt A, David G, Vlodavsky I, Yayon A (1994) Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J Biol Chem 269:114-121
40. Rahmoune H, Rudland PS, Gallagher JT, Fernig DG (1998) Hepatocyte growth factor/scatter factor has distinct classes of binding site in heparan sulfate from mammary cells. Biochemistry 37:6003-6008
41. Ten Dam GB, Kurup S, van de Westerlo EM, Versteeg EM, Lindahl U, Spillmann D, van Kuppevelt TH (2006) 3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3. J Biol Chem 281:4654-4662
42. ten Dam GB, van de Westerlo EM, Smetsers TF, Willemse M, van Muijen GN, Merry CL, Gallagher JT, Kim YS, van Kuppevelt TH (2004) Detection of 2-O-sulfated iduronate and N-acetylglucosamine units in heparan sulfate by an antibody selected against acharan sulfate (IdoA2S-Glc-NAc)n. J Biol Chem 279:38346-38352
43. Dennissen MA, Jenniskens GJ, Pieffers M, Versteeg EM, Petitou M, Veerkamp JH, van Kuppevelt TH (2002) Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies. J Biol Chem 277:10982-10986
44. Jesudason EC, Connell MG, Fernig DG, Lloyd DA, Losty PD (2000) Early lung malformations in congenital diaphragmatic hernia. J Pediatr Surg 35:124-127, discussion 2